$CBRS

Feldman Andrew D. sold $3.1M of CBRS

Feldman Andrew D. (CEO, President) sold 17,990 shares of Cerebras Systems Inc. (CBRS) at an average of $173.06 ($169.07–$184.73, $3.11M total) across 12 trades on 2026-06-25.

Original reporting
SEC EDGAR · Feldman Andrew D.
Published Jun 29, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 7:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CBRS
Neutral
medium confidence
Mentioned
$CBRS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBRSNeutralLow
01

Why it matters

The disclosure provides a concrete insider selling event (size, dates, price range, and post-transaction holdings), which may influence short-term sentiment but does not change the company’s fundamentals on its own.

02

Market read

Traders may monitor for follow-on insider activity or any concurrent company news, but this filing alone is unlikely to drive a durable repricing.

03

What to watch

The article does not state motivations, tax planning, or whether other insiders or the company have concurrent catalysts; traders should avoid over-weighting insider-sale narratives without corroborating news.

Relevance 6/10Novelty 4/10Timing: filed 2026-06-29 after trades on 2026-06-25

Background

The article is a SEC Form 4 insider transaction disclosure for Cerebras Systems Inc. (CBRS).

Company-level read

Ticker impact

$CBRSNeutralMedium confidence
Context

Cerebras Systems CEO Andrew Feldman sold about $3.11M of CBRS shares in an open-market Form 4, leaving 0 shares after the trades.

Expected impact

Near-term sentiment impact is likely limited, with any price reaction more dependent on broader tape and company-specific catalysts than this filing alone.

Evidence & confidence

The filing discloses transaction size, pricing range, and that holdings fell to zero, but it does not provide new operational, financial, or regulatory information.

Market effects

Minimal, as this is a single-company insider transaction without sector-wide signal.

None indicated.

None indicated.

Counterpoint

The sale could be routine liquidity or diversification, and the absence of a stated 10b5-1 plan does not necessarily imply negative fundamentals.

Key entities

  • Cerebras Systems Inc.

    Subject of the Form 4 insider sale by its CEO/President.

  • Andrew D. Feldman

    CEO and President who sold shares and reported 0 shares after the transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CBRSMed

Cerebras stock jumps 9%; Q3 sales guide sets a harder test

Cerebras Systems (CBRS) stock rose 9% after OpenAI's Sam Altman reaffirmed their partnership. The company's Q3 revenue guidance suggests 2.4% sequential growth. OpenAI committed to 750MW of capacity, with an option for 1.25GW. Cerebras reported $56.8M in OpenAI-related revenue in Q2, 31.5% of total GAAP revenue. The stock remains below its IPO price of $185.

$CBRSHigh

CBRS Stock Surges Over 6% in Monday Pre-Market: What's the Sam Altman Connection? - Cerebras Systems (NAS

Cerebras Systems (CBRS) shares rose 6.56% premarket after OpenAI CEO Sam Altman called it a 'close partner,' easing concerns. Analysts noted strong ties with OpenAI, despite Nvidia (NVDA) running its new model. Barclays' Tom O'Malley called the sell-off 'overdone,' while Paul Meeks upgraded CBRS to Buy with a $209 target, citing high AI demand. CBRS is down 52.45% YTD.

$CBRSMed

Mizuho reiterates Cerebras Systems stock rating on inference growth

Mizuho reiterated its Outperform rating and $300 price target for Cerebras Systems (CBRS), citing growth in fast inference workloads. The firm projects a $550B market by 2030, with CBRS trading near its 52-week low at $166.43. CBRS reported 91% revenue growth over the last year, and analysts have revised earnings upwards, though some suggest overvaluation. The company unveiled the CS-4 system, with improved performance and compute density, expected in Q3.